Affiliation:
1. Organisch-Chemisches Institut, Universität Zürich, Zürich, Switzerland
2. Departement Medizinische Parasitologie und Infektionsbiologie, Schweizerisches Tropeninstitut, Basel, Switzerland
3. Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom
4. Institut für Pharmazeutische Biologie und Phytochemie, Westfälische Wilhelms-Universität Münster, Münster, Germany
5. Department Pharmacognosy, Faculty of Pharmacy, Gazi University, Ankara, Turkey
Abstract
ABSTRACT
Trypanosomiasis and leishmaniasis are important parasitic diseases affecting millions of people in Africa, Asia, and South America. In a previous study, we identified several flavonoid glycosides as antiprotozoal principles from a Turkish plant. Here we surveyed a large set of flavonoid aglycones and glycosides, as well as a panel of other related compounds of phenolic and phenylpropanoid nature, for their in vitro activities against
Trypanosoma brucei rhodesiense
,
Trypanosoma cruzi
, and
Leishmania donovani
. The cytotoxicities of more than 100 compounds for mammalian L6 cells were also assessed and compared to their antiparasitic activities. Several compounds were investigated in vivo for their antileishmanial and antitrypanosomal efficacies in mouse models. Overall, the best in vitro trypanocidal activity for
T. brucei rhodesiense
was exerted by 7,8-dihydroxyflavone (50% inhibitory concentration [IC
50
], 68 ng/ml), followed by 3-hydroxyflavone, rhamnetin, and 7,8,3′,4′-tetrahydroxyflavone (IC
50
s, 0.5 μg/ml) and catechol (IC
50
, 0.8 μg/ml). The activity against
T. cruzi
was moderate, and only chrysin dimethylether and 3-hydroxydaidzein had IC
50
s less than 5.0 μg/ml. The majority of the metabolites tested possessed remarkable leishmanicidal potential. Fisetin, 3-hydroxyflavone, luteolin, and quercetin were the most potent, giving IC
50
s of 0.6, 0.7, 0.8, and 1.0 μg/ml, respectively. 7,8-Dihydroxyflavone and quercetin appeared to ameliorate parasitic infections in mouse models. Generally, the test compounds lacked cytotoxicity in vitro and in vivo. By screening a large number of flavonoids and analogues, we were able to establish some general trends with respect to the structure-activity relationship, but it was not possible to draw clear and detailed quantitative structure-activity relationships for any of the bioactivities by two different approaches. However, our results can help in directing the rational design of 7,8-dihydroxyflavone and quercetin derivatives as potent and effective antiprotozoal agents.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Reference36 articles.
1. Cultivation in a semi-defined medium of animal infective forms of Trypanosoma brucei, T. equiperdum, T. evansi, T. rhodesiense and T. gambiense.
2. Bürgi C. B. 1991. Isolierung Strukturaufklaerung und Synthese von antioxidativ wirksamen langkettigen Alkylphenolen aus Plectranthus albidus (Labiatae). Ph.D. thesis. University of Zurich Zurich Switzerland.
3. Camacho, M. D. R., J. D. Phillipson, S. L. Croft, D. Marley, G. C. Kirby, and D. C. Warhurst. 2002. Assessment of the antiprotozoal activity of Galphimia glauca and the isolation of new nor-secofriedelanes and nor-friedelanes. J. Nat. Prod.65:1457-1461.
4. Croft, S. L., and V. Yardley. 1999. Animal models of visceral leishmaniasis, p. 783-787. In O. Zak (ed.), Handbook of animal models of infection. Academic Press, Inc., New York, N.Y.
5. Cunningham, I. 1977. New culture medium for maintenance of tsetse tissues and growth of trypanosomatids. J. Protozool.24:325-329.